The CRO concept continued to rise in the intraday market. Nanmo Biotech rose and stopped 20 cm. Previously, Broji Pharmaceuticals rose 20 cm, Wanbang Pharmaceutical rose 18%, and nearshore protein, Haoyuan Pharmaceuticals, Wisdom Pharmaceuticals, Opumai, and Bioosetu registered higher gains.

The CRO concept continued to rise in the intraday market. Nanmo Biotech rose and stopped 20 cm. Previously, Broji Pharmaceuticals rose 20 cm, Wanbang Pharmaceutical rose 18%, and nearshore protein, Haoyuan Pharmaceuticals, Wisdom Pharmaceuticals, Opumai, and Bioosetu registered higher gains.